Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
Genentech pays Alector $100M for preclinical Parkinson’s asset
Genentech is committing up to $1.17 billion in milestones and tiered royalties on net sales.
Nick Paul Taylor
Oct 5, 2026 10:09am
Gate CEO sees expanded $870M Lilly pact as ‘vote of confidence’
Oct 5, 2026 8:00am
CSL pays $355M to co-develop Alentis’ ph. 2-stage fibrosis drug
Oct 5, 2026 4:14am
Novartis pens $7.8B deal for Abogen's in vivo autoimmune TCE
Oct 2, 2026 4:24am
Foghorn lays off 40% of employees as Lilly collab collapses
Oct 1, 2026 8:36am
Sanofi pays Regeneron $1B for 4 early-stage assets to ignite R&D
Oct 1, 2026 4:24am
